A randomised Australian trial finds breast density notification raises anxiety and confusion and increases GP consultation ...
News-Medical.Net on MSN
AI language models actually help in digestive disease care
Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...
BIRMINGHAM, AL, UNITED STATES, January 8, 2026 / EINPresswire.com / — Rampart, a Birmingham, Alabama–based medical device ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, announced key milestones achieved in 2025, a year defined by progress, innovation, and growth. Vektor's flagship ...
Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction ...
A new study provides novel insights into the durability of endovascular thrombectomy in patients with stroke caused by ...
Medium on MSN
5 mouthwashes with links to increased cancer risks
Mouthwashes are designed to rinse out potential bacteria while leaving you with fresh breath. However, some may increase your ...
BioMendics advances its TAMES-02 trial of TolaSure™, a potential disease-modifying topical therapy for Epidermolysis Bullosa ...
MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials.
Here’s what to know about body composition numbers and what these metrics mean for your health and performance.
SynuSight Biotech has licensed 18F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...
For more information about IPACE-HIV, please visit clinicaltrials.gov.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback